PUBLISHED 2021

The 92nd Edition HDA Factbook (2021–2022) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry. The data examined within the report are from fiscal year 2020 — and reflect the impact of COVID-19.

Included is information on distributor demographics, operations, finances, customers and information systems use, as well as analysis of healthcare product sales and trends, U.S. market characteristics (prescription use/healthcare expenditures) and a brief overview of the international marketplace.

Updates for the 2021 Edition:
New to the benchmark are capital expenditure trends in dollars, payroll and gross profit per employee, and data for days sales in inventory broken out by branded versus generic products (Finance section); as well as reasons goods are returned to manufacturers and the number of PPE SKUs per company (Operations section).

Additionally, distributor net sales growth data were moved to Table 2 in the Distributor Demographics and Characteristics section.

Publication Sponsors

Gold: Apotex Corp. and Real Value Rx dba Hospital Pharmaceutical Consulting
Bronze: Ascend Laboratories, LLC; IQVIA; Johnson & Johnson Health Care Systems Inc.; Pharmacy First; and Teva Pharmaceuticals